What is the equity of Recursion Pharmaceuticals this year?
Recursion Pharmaceuticals has equity of 463.44 M USD this year.
Recursion Pharmaceuticals Equity 2024
Recursion Pharmaceuticals Equity
463.44 M USD
Recursion Pharmaceuticals Dividend yield
Ticker
RXRX
ISIN
US75629V1044
In 2024, Recursion Pharmaceuticals's equity was 463.44 M USD, a -4.6% increase from the 485.8 M USD equity in the previous year.
Recursion Pharmaceuticals Aktienanalyse
What does Recursion Pharmaceuticals do?
Recursion Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Recursion Pharmaceuticals's Equity
Recursion Pharmaceuticals's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Recursion Pharmaceuticals's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Recursion Pharmaceuticals's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Recursion Pharmaceuticals's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Recursion Pharmaceuticals’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Recursion Pharmaceuticals Stock
What was the equity of Recursion Pharmaceuticals compared to the previous year?
The equity of Recursion Pharmaceuticals has increased/decreased by -4.6% decreased compared to the previous year.
What impact does a high equity have on investors of Recursion Pharmaceuticals?
A high equity is advantageous for investors of Recursion Pharmaceuticals as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Recursion Pharmaceuticals?
A low equity can be a risk for investors of Recursion Pharmaceuticals, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Recursion Pharmaceuticals affect the company?
An increase in equity of Recursion Pharmaceuticals can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Recursion Pharmaceuticals affect the company?
A reduction in equity of Recursion Pharmaceuticals can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Recursion Pharmaceuticals?
Some factors that can affect the equity of Recursion Pharmaceuticals include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Recursion Pharmaceuticals so important for investors?
The equity of Recursion Pharmaceuticals is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Recursion Pharmaceuticals take to change the equity?
To change equity, Recursion Pharmaceuticals can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Recursion Pharmaceuticals pay?
Over the past 12 months, Recursion Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Recursion Pharmaceuticals is expected to pay a dividend of 0 USD.
What is the dividend yield of Recursion Pharmaceuticals?
The current dividend yield of Recursion Pharmaceuticals is .
When does Recursion Pharmaceuticals pay dividends?
Recursion Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Recursion Pharmaceuticals?
Recursion Pharmaceuticals paid dividends every year for the past 0 years.
What is the dividend of Recursion Pharmaceuticals?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Recursion Pharmaceuticals located?
Recursion Pharmaceuticals is assigned to the 'Health' sector.
Wann musste ich die Aktien von Recursion Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Recursion Pharmaceuticals from 6/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/1/2024.
When did Recursion Pharmaceuticals pay the last dividend?
The last dividend was paid out on 6/1/2024.
What was the dividend of Recursion Pharmaceuticals in the year 2023?
In the year 2023, Recursion Pharmaceuticals distributed 0 USD as dividends.
In which currency does Recursion Pharmaceuticals pay out the dividend?
The dividends of Recursion Pharmaceuticals are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Recursion Pharmaceuticals
Our stock analysis for Recursion Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Recursion Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Recursion Pharmaceuticals Revenue
- Recursion Pharmaceuticals Net Income
- Recursion Pharmaceuticals P/E
- Recursion Pharmaceuticals P/S
- Recursion Pharmaceuticals EBIT
- Recursion Pharmaceuticals Dividend
- Recursion Pharmaceuticals Stocks
- Recursion Pharmaceuticals Market capitalization
- Recursion Pharmaceuticals Debt
- Recursion Pharmaceuticals Liabilities
- Recursion Pharmaceuticals Equity
- Recursion Pharmaceuticals AAQS
- Recursion Pharmaceuticals Employees
- Recursion Pharmaceuticals ROE
- Recursion Pharmaceuticals ROA
- Recursion Pharmaceuticals ROCE